Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

September 29, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Dalal Street, Mumbai - 400 051 Mumbai - 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Ma’am, Pursuant to Regulation 30 of the SEBI Listing Regulations, it is hereby informed that the Company has received a Show Cause Notice dated September 28, 2026 from the Office of the Assistant Commissioner, CGST, Gurugram in relation to the financial year 2022-23. The relevant details pursuant to Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI Circulars are annexed herewith as Annexure - A. Please note that the Company had already filed a writ petition before the Hon’ble High Court of Punjab & Haryana, Chandigarh in relation to a Show Cause Notice issued for an earlier period concerning the same matter as covered under the aforesaid Show Cause Notice. The necessary disclosure in this regard was made by the Company on November 22, 2024. In the said writ, the Hon’ble High Court vide its interim order stayed the further proceedings in the concerned matter. The Company is in the process of filing a writ before the Hon’ble High Court of Punjab & Haryana, Chandigarh in relation to the aforesaid Show Cause Notice dated September 28, 2026 and to connect the matter with the previous writ. In respect of the captioned matter, we hereby also state and declare that the information and details provided in Annexure A, in compliance with Regulation 30(13) of the SEBI Listing Regulations, are true, correct and complete to the best of our knowledge and belief. This is for your information and records. Thanking you, Yours faithfully, For Artemis Medicare Services Limited Poonam Makkar Company Secretary and Compliance Officer Encl.: As above Annexure - A Information as per Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S. No. Particulars Details 1. Name of the listed company Artemis Medicare Services Limited (“the Company”) 2. Type of communication received Show Cause Notice 3. Date of receipt of communication September 29, 2026 at 10:30 A.M. (IST) 4. Authority from whom communication Office of the Assistant Commissioner, CGST, received Gurugram 5. Brief summary of the material contents of The Goods and Service Tax Department the communication received, including alleged that the Company is charging MRP reasons for receipt of the communication from in-patients (IPD) on medicines, consumables and implants supplied while providing Healthcare Services which includes GST and not remitting the same to the Government. 6. Period for which communication would be From April 1, 2022 to March 31, 2023 applicable, if stated 7. Brief details of litigation Same as disclosed in point no. 5 above 8. Details of any aberrations/ non- Not applicable compliances identified by the authority in the communication 9. Details of any penalty or restriction or Not applicable sanction imposed pursuant to the communication 10. Expected financial implications, if any, Rs. 11.11 Crore and interest & penalty thereon due to compensation, penalty etc. 11. Quantum of claims, if any Rs. 11.11 Crore and interest & penalty thereon 12. Action(s) taken by listed company with The Company is in the process of filing a respect to the communication writ before the Hon’ble High Court of Punjab & Haryana, Chandigarh in relation to the aforesaid Show Cause Notice and to connect the matter with the previous pending writ wherein stay has already been granted. 13. Any other relevant information None